Index of reports
> Cases with Depression (13)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Estraderm (Estradiol Transdermal) where reactions include depression. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Estraderm side effects in female
Reported by a consumer/non-health professional from Brazil on 2012-05-07
Patient: female, weighing 53.0 kg (116.6 pounds)
Reactions: Skin Fragility, Panic Disorder, Hyperhidrosis, Skin Discolouration, Feeling Hot, Capillary Fragility, Blood Cholesterol Increased, Depression, Hypertension
Drug(s) suspected as cause:
Estraderm
Dosage: 50 mcg, 1 patch every 3 or 4 days (2 times weekly)
Indication: Menopausal Symptoms
Estraderm
Dosage: 25, 1 patch every 3 or 4 days
Indication: Menopausal Symptoms
Start date: 1995-01-01
Other drugs received by patient: Simvastatin; Sertraline Hydrochloride; Vitamin C; Atenolol and Chlorthalidone
Possible Estraderm side effects in 39 year old female
Reported by a consumer/non-health professional from United Kingdom on 2012-05-02
Patient: 39 year old female
Reactions: Anxiety, Panic Attack, Fatigue, Hot Flush, Blood Oestrogen Decreased, Depression
Drug(s) suspected as cause:
Estraderm
Other drugs received by patient: Estrogel; Testim; Estrogel
Possible Estraderm side effects in female
Reported by a physician from United States on 2012-02-10
Patient: female
Reactions: Thrombosis, Asthma, Lymphadenopathy, Hypoglycaemia, Osteomyelitis, Lipids Increased, Cerebrovascular Disorder, Peripheral Sensory Neuropathy, Oedema Peripheral, Uterine Leiomyoma, Irritable Bowel Syndrome, Postmenopausal Haemorrhage, Hypoxia, Breast Cancer, Pneumonia, Pain in Extremity, Mastitis, Breast Mass, Hypoaesthesia, Diverticulum Intestinal, Adenomyosis, Diabetic Neuropathy, Staphylococcal Infection, Nervous System Disorder, Gastric Polyps, non-Hodgkin's Lymphoma, Sleep Apnoea Syndrome, Uterine Haemorrhage, Aphasia, Viith Nerve Paralysis, Fibrocystic Breast Disease, Neuropathy Peripheral, Fibromyalgia, Obesity, Depression, Lymphoedema, Transient Ischaemic Attack, Migraine, Abdominal Pain Lower, Type 2 Diabetes Mellitus, Motor Dysfunction, Urinary Tract Infection, Cognitive Disorder, Cystitis, Amnesia, Cerebrovascular Accident, Anxiety, Osteoarthritis, Dysarthria, Diarrhoea, Arthralgia, Dysuria, Flank Pain, Alopecia, Gait Disturbance, Hypertension
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Estraderm
Dosage: 0.5 mg, unk
Indication: Hormone Replacement Therapy
Start date: 1994-04-01
End date: 1997-06-01
Vivelle
Dosage: 0.1 mg, unk
Indication: Hormone Replacement Therapy
Start date: 1997-10-01
End date: 1997-12-01
Provera
Dosage: 2.5 mg, unk
Administration route: Oral
Indication: Hormone Replacement Therapy
Start date: 1994-03-01
End date: 1994-08-01
Premarin
Indication: Hormone Replacement Therapy
Medroxyprogesterone Acetate
Dosage: 2.5 mg, unk
Administration route: Oral
Indication: Hormone Replacement Therapy
Start date: 1994-09-01
End date: 2000-02-16
Estraderm
Dosage: 0.1 mg, unk
Start date: 1997-08-01
End date: 2000-02-01
Possible Estraderm side effects in female
Reported by a pharmacist from United States on 2012-01-18
Patient: female, weighing 64.4 kg (141.7 pounds)
Reactions: Asthma, Weight Decreased, Abdominal Pain, Metastases To Liver, Fungal Sepsis, Pyrexia, Chronic Obstructive Pulmonary Disease, Iron Deficiency Anaemia, Poisoning, Immunosuppression, Hydronephrosis, Hiatus Hernia, Fistula, Anaemia, Hyperglycaemia, Malnutrition, Pancytopenia, Left Ventricular Hypertrophy, Intestinal Obstruction, Malignant Neoplasm of Uterine Adnexa, Hepatic Steatosis, Cholelithiasis, Hepatic Cyst, Dehydration, Abscess, Metastases To Kidney, Neutropenia, Scar, Confusional State, Jaundice, Bone Pain, Pain, Chills, Mental Status Changes, Short-Bowel Syndrome, Constipation, Fall, Laryngitis, Hypokalaemia, Pancreatic Duct Dilatation, Fatigue, Postoperative Wound Infection, Chest Pain, Hydroureter, Pleural Effusion, Dizziness, Oedema, Electrolyte Imbalance, Depression, Decreased Appetite, Abdominal Pain Lower, Vomiting, Dyspnoea, Nausea, Urinary Tract Infection, Post Gastric Surgery Syndrome, Muscular Weakness, Anxiety, Intestinal Haemorrhage, Diarrhoea, Arthralgia, Spinal Osteoarthritis, Hypertension, Ovarian Cancer
Adverse event resulted in: death
Drug(s) suspected as cause:
Estraderm
Dosage: unk
Indication: Hormone Replacement Therapy
Start date: 1985-01-01
End date: 2003-01-01
Taxol
Carboplatin
Compazine
Topotecan
Estradiol
Dosage: unk
Indication: Hormone Replacement Therapy
Start date: 1985-01-01
End date: 2003-01-01
Doxil
Neulasta
Dosage: unk
Other drugs received by patient: Nitrofurantoin; Methylprednisolon ^jenapharm^; Ibuprofen; Metronidazol ^alpharma^; Metrogel; Cephalexin; Roxicet; Alprazolam; Dexamethasone TAB; Zithromax; Sertraline Hydrochloride; Monopril; Adipex; Robinul Forte; Enalapril Maleate; Ambien; Biaxin; Naproxen Sodium; Tamoxifen Citrate; Cefadroxil; Promethazine; Ciprofloxacin; Cyclobenzaprine; Premarin; Cleocin Hydrochloride; Dicyclomine; Temazepam; Chemotherapeutics NOS; Morphine; Fluconazole; Miralax
Possible Estraderm side effects in female
Reported by a lawyer from United States on 2012-01-12
Patient: female
Reactions: Asthma, Thrombosis, Lymphadenopathy, Hypoglycaemia, Cerebrovascular Disorder, Lipids Increased, Peripheral Sensory Neuropathy, Uterine Leiomyoma, Irritable Bowel Syndrome, Hypoxia, Postmenopausal Haemorrhage, Breast Cancer, Pneumonia, Pain in Extremity, Breast Mass, Hypoaesthesia, Diverticulum Intestinal, Adenomyosis, Staphylococcal Infection, Diabetic Neuropathy, Nervous System Disorder, Gastric Polyps, non-Hodgkin's Lymphoma, Sleep Apnoea Syndrome, Uterine Haemorrhage, Aphasia, Viith Nerve Paralysis, Neuropathy Peripheral, Fibrocystic Breast Disease, Fibromyalgia, Obesity, Depression, Lymphoedema, Transient Ischaemic Attack, Migraine, Abdominal Pain Lower, Type 2 Diabetes Mellitus, Motor Dysfunction, Cognitive Disorder, Amnesia, Cerebrovascular Accident, Osteoarthritis, Dysarthria, Anxiety, Arthralgia, Diarrhoea, Gait Disturbance, Hypertension
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Estraderm
Dosage: 0.5 mg, unk
Indication: Hormone Replacement Therapy
Start date: 1994-04-01
End date: 1997-06-01
Vivelle
Dosage: 0.1 mg, unk
Indication: Hormone Replacement Therapy
Start date: 1997-10-01
End date: 1997-12-01
Premarin
Indication: Hormone Replacement Therapy
Provera
Dosage: 2.5 mg, unk
Administration route: Oral
Indication: Hormone Replacement Therapy
Start date: 1994-03-01
End date: 1994-08-01
Estraderm
Dosage: 0.1 mg, unk
Start date: 1997-08-01
End date: 2000-02-01
Medroxyprogesterone Acetate
Dosage: 2.5 mg, unk
Administration route: Oral
Indication: Hormone Replacement Therapy
Start date: 1994-09-01
End date: 2000-02-16
Possible Estraderm side effects in female
Reported by a individual with unspecified qualification from United States on 2012-01-09
Patient: female, weighing 89.8 kg (197.6 pounds)
Reactions: Abdominal Pain, Fall, Cardiac Disorder, Cardiac Valve Disease, Facial Paresis, Hot Flush, Neck Pain, Palpitations, Dyspepsia, Abdominal Distension, Depression, Fibrosis, Lymphoedema, Breast Cancer, Back Pain, Metastatic Neoplasm, Breast Disorder, Renal Cyst, Joint Injury, Diverticulum Intestinal, Arrhythmia, Pulmonary Fibrosis, Cutis Laxa, Hypertension, Face Injury, Leukopenia
Drug(s) suspected as cause:
Prempro
Dosage: .625/2.5mg qd
Administration route: Oral
Indication: Menopausal Symptoms
Start date: 1999-01-01
End date: 2001-04-01
Estraderm
Dosage: unk biw
Administration route: Topical
Indication: Menopausal Symptoms
Start date: 1997-09-20
End date: 1999-01-01
Other drugs received by patient: Tamoxifen Citrate; Lopressor; Cytoxan; Celexa; Adriamycin PFS; Femara; Vicodin; Vicodin; Prozac; Maxzide
Possible Estraderm side effects in female
Reported by a physician from United States on 2012-01-09
Patient: female, weighing 64.4 kg (141.7 pounds)
Reactions: Asthma, Abdominal Pain, Metastases To Liver, Fungal Sepsis, Pyrexia, Chronic Obstructive Pulmonary Disease, Iron Deficiency Anaemia, Poisoning, Immunosuppression, Fistula, Hiatus Hernia, Hydronephrosis, Hyperglycaemia, Anaemia, Malnutrition, Pancytopenia, Left Ventricular Hypertrophy, Malignant Neoplasm of Uterine Adnexa, Intestinal Obstruction, Hepatic Steatosis, Cholelithiasis, Hepatic Cyst, Dehydration, Neutropenia, Abscess, Metastases To Kidney, Scar, Confusional State, Pain, Chills, Bone Pain, Mental Status Changes, Short-Bowel Syndrome, Constipation, Fall, Hypokalaemia, Laryngitis, Pancreatic Duct Dilatation, Postoperative Wound Infection, Fatigue, Chest Pain, Hydroureter, Dizziness, Pleural Effusion, Oedema, Depression, Electrolyte Imbalance, Decreased Appetite, Abdominal Pain Lower, Vomiting, Dyspnoea, Nausea, Urinary Tract Infection, Post Gastric Surgery Syndrome, Muscular Weakness, Intestinal Haemorrhage, Anxiety, Arthralgia, Diarrhoea, Spinal Osteoarthritis, Hypertension, Ovarian Cancer
Adverse event resulted in: death
Drug(s) suspected as cause:
Carboplatin
Estradiol
Dosage: unk
Indication: Hormone Replacement Therapy
Start date: 1985-01-01
End date: 2003-01-01
Neulasta
Dosage: unk
Doxil
Topotecan
Estraderm
Dosage: unk
Indication: Hormone Replacement Therapy
Start date: 1985-01-01
End date: 2003-01-01
Compazine
Taxol
Other drugs received by patient: Robinul Forte; Ciprofloxacin; Zithromax; Enalapril Maleate; Metrogel; Methylprednisolon ^jenapharm^; Adipex; Alprazolam; Ibuprofen; Biaxin; Temazepam; Nitrofurantoin; Dexamethasone; Tamoxifen Citrate; Premarin; Cephalexin; Cleocin Hydrochloride; Monopril; Dicyclomine; Ambien; Fluconazole; Sertraline Hydrochloride; Cefadroxil; Chemotherapeutics NOS; Roxicet; Morphine; Metronidazol ^alpharma^; Naproxen Sodium; Cyclobenzaprine; Promethazine; Miralax
Possible Estraderm side effects in female
Reported by a individual with unspecified qualification from United States on 2011-12-01
Patient: female, weighing 61.2 kg (134.7 pounds)
Reactions: Abdominal Pain, Muscle Atrophy, Breast Cancer in Situ, Loss of Consciousness, Breast Cancer Recurrent, Metastasis, Dyspepsia, Vulvovaginal Dryness, Mammogram, Breast Hyperplasia, Back Pain, Dyspareunia, Intervertebral Disc Protrusion, Dysphagia, Oestrogen Receptor Assay Negative, Breast Cancer Stage I, Ovarian Cyst, Breast Cancer Stage III, Breast Mass, Renal Cyst, Osteopenia, Colitis, Breast Necrosis, Excessive Granulation Tissue, Confusional State, Application Site Reaction, Head Injury, Osteoporosis, Pain, Fall, Weight Increased, Fibrocystic Breast Disease, Chest Pain, Intervertebral Disc Degeneration, Injury, Oestrogen Receptor Assay Positive, Depression, Hallucination, Gastrooesophageal Reflux Disease, Progesterone Receptor Assay Negative, Scoliosis, Bone Giant Cell Tumour, Radius Fracture, Anxiety, Atrophic Vulvovaginitis, Spinal Osteoarthritis, Arthritis, Physical Disability, Breast Fibrosis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Premarin
Dosage: 0.625 mg, unk
Administration route: Oral
Start date: 1992-10-01
End date: 1997-07-01
Provera
Dosage: 5/2.5 mg day 1-14
Administration route: Oral
Start date: 1992-10-01
End date: 1997-07-01
Ogen
Start date: 1992-06-01
End date: 1993-04-01
Estraderm
Dosage: 0.05 mg, 2x/wk
Start date: 1995-09-01
End date: 1995-11-01
Prempro
Dosage: 625/2.5 mg
Indication: Menopausal Symptoms
Start date: 1996-06-01
End date: 1996-06-01
Premarin
Other drugs received by patient: Multivitamins, Combinations; Xanax; Prozac; Evista
Possible Estraderm side effects in female
Reported by a physician from United States on 2011-12-01
Patient: female, weighing 68.0 kg (149.6 pounds)
Reactions: Foot Deformity, Abdominal Pain, Endometrial Hyperplasia, Aortic Stenosis, Chronic Obstructive Pulmonary Disease, Vitamin B12 Deficiency, Dyspepsia, Uterine Leiomyoma, Breast Hyperplasia, Metabolic Disorder, Arteriosclerosis, Breast Cancer, Cardiac Murmur, Hiatus Hernia, Ovarian Cyst, Coronary Artery Disease, Breast Mass, Cervical Dysplasia, Insomnia, Pelvic Pain, Fibrocystic Breast Disease, Fatigue, Chest Pain, Liver Function Test Abnormal, Dizziness, Depression, Gastrooesophageal Reflux Disease, Dyspnoea, Nausea, Amnesia, Rectocele, Dysuria, Visual Impairment
Drug(s) suspected as cause:
Premarin
Dosage: 0.625 mg, unk
Indication: Menopause
Start date: 1990-11-26
End date: 2000-11-01
Provera
Dosage: 10 mg, unk
Start date: 1990-11-26
Medroxyprogesterone
Indication: Menopause
Start date: 1991-01-01
Provera
Dosage: 2.5 mg, unk
End date: 2000-11-01
Ogen
Provera
Indication: Menopause
Start date: 1988-01-01
End date: 1991-01-01
Premarin
Start date: 1988-01-01
End date: 1991-01-01
Prempro
Provera
Start date: 1991-01-01
Premarin
Administration route: Topical
Indication: Menopause
Start date: 1992-03-11
End date: 1997-11-23
Hormones
Administration route: Topical
Indication: Menopause
Start date: 1991-01-01
Climara
Estraderm
Indication: Menopause
Start date: 1991-01-01
End date: 1993-03-11
Estraderm
Dosage: 0.05 mg, biw
Start date: 1992-03-11
End date: 1993-03-11
Cycrin
Dosage: 2.5 mg, unk
Indication: Menopause
Start date: 1997-11-17
End date: 1997-12-17
Other drugs received by patient: Calcium Carbonate; Fosamax; Plavix; Prednisone TAB; Tamoxifen Citrate; Zantac; Magnesium Sulfate; Tricor; Methotrexate; Fluconazole; Paxil; Naproxen (Aleve); Aspirin; Prevacid; Macrodantin; Folic Acid; Zoloft
Possible Estraderm side effects in female
Reported by a lawyer from United States on 2011-11-29
Patient: female, weighing 68.0 kg (149.6 pounds)
Reactions: Abdominal Pain, Aortic Stenosis, Pelvic Pain, Chronic Obstructive Pulmonary Disease, Fatigue, Fibrocystic Breast Disease, Dyspepsia, Uterine Leiomyoma, Chest Pain, Liver Function Test Abnormal, Dizziness, Breast Hyperplasia, Depression, Arteriosclerosis, Breast Cancer, Cardiac Murmur, Hiatus Hernia, Nausea, Breast Mass, Ovarian Cyst, Cervical Dysplasia, Amnesia, Rectocele, Visual Impairment
Drug(s) suspected as cause:
Provera
Dosage: 10 mg, unk
Start date: 1990-11-26
Cycrin
Dosage: 2.5 mg, unk
Indication: Menopause
Start date: 1997-11-17
End date: 1997-12-17
Prempro
Hormones
Administration route: Topical
Indication: Menopause
Start date: 1991-01-01
Ogen
Provera
Start date: 1991-01-01
Premarin
Dosage: 0.625 mg, unk
Indication: Menopause
Start date: 1990-11-26
End date: 2000-11-01
Premarin
Administration route: Topical
Indication: Menopause
Start date: 1992-03-11
End date: 1997-11-23
Estraderm
Dosage: 0.05 mg, biw
Start date: 1992-03-11
End date: 1993-03-11
Premarin
Start date: 1988-01-01
End date: 1991-01-01
Medroxyprogesterone
Indication: Menopause
Start date: 1991-01-01
Provera
Indication: Menopause
Start date: 1988-01-01
End date: 1991-01-01
Provera
Dosage: 2.5 mg, unk
End date: 2000-11-01
Climara
Estraderm
Indication: Menopause
Start date: 1991-01-01
End date: 1993-03-11
Other drugs received by patient: Methotrexate; Aspirin; Naproxen (Aleve); Magnesium Sulfate; Plavix; Macrodantin; Tamoxifen Citrate; Zantac; Prevacid; Fluconazole; Paxil; Prednisone; Folic Acid; Zoloft; Calcium Carbonate; Fosamax; Tricor
Possible Estraderm side effects in female
Reported by a pharmacist from United States on 2011-11-28
Patient: female, weighing 64.4 kg (141.7 pounds)
Reactions: Asthma, Fungal Sepsis, Pyrexia, Chronic Obstructive Pulmonary Disease, Iron Deficiency Anaemia, Poisoning, Immunosuppression, Hiatus Hernia, Fistula, Hydronephrosis, Anaemia, Hyperglycaemia, Malnutrition, Left Ventricular Hypertrophy, Pancytopenia, Intestinal Obstruction, Malignant Neoplasm of Uterine Adnexa, Hepatic Steatosis, Cholelithiasis, Hepatic Cyst, Dehydration, Abscess, Neutropenia, Scar, Pain, Bone Pain, Chills, Mental Status Changes, Short-Bowel Syndrome, Constipation, Pancreatic Duct Dilatation, Hypokalaemia, Laryngitis, Postoperative Wound Infection, Fatigue, Hydroureter, Chest Pain, Oedema, Pleural Effusion, Dizziness, Depression, Electrolyte Imbalance, Decreased Appetite, Abdominal Pain Lower, Vomiting, Nausea, Urinary Tract Infection, Muscular Weakness, Intestinal Haemorrhage, Anxiety, Diarrhoea, Spinal Osteoarthritis, Hypertension, Ovarian Cancer
Adverse event resulted in: death
Drug(s) suspected as cause:
Doxil
Topotecan
Estraderm
Dosage: unk
Indication: Hormone Replacement Therapy
Start date: 1985-01-01
End date: 2003-01-01
Estradiol
Dosage: unk
Indication: Hormone Replacement Therapy
Start date: 1985-01-01
End date: 2003-01-01
Compazine
Taxol
Carboplatin
Neulasta
Dosage: unk
Other drugs received by patient: Promethazine; Nitrofurantoin; Methylprednisolon ^jenapharm^; Cefadroxil; Adipex; Enalapril Maleate; Monopril; Robinul Forte; Alprazolam; Zithromax; Dicyclomine; Dexamethasone; Tamoxifen Citrate; Biaxin; Miralax; Morphine; Ciprofloxacin; Metronidazol ^alpharma^; Sertraline Hydrochloride; Cleocin Hydrochloride; Naproxen Sodium; Ambien; Fluconazole; Cyclobenzaprine; Premarin; Cephalexin; Temazepam; Ibuprofen; Metrogel; Roxicet; Chemotherapeutics NOS
Possible Estraderm side effects in female
Reported by a individual with unspecified qualification from United States on 2011-11-28
Patient: female, weighing 89.8 kg (197.6 pounds)
Reactions: Fall, Cardiac Disorder, Cardiac Valve Disease, Facial Paresis, Hot Flush, Neck Pain, Palpitations, Depression, Fibrosis, Lymphoedema, Breast Cancer, Back Pain, Metastatic Neoplasm, Breast Disorder, Joint Injury, Arrhythmia, Cutis Laxa, Hypertension, Face Injury, Leukopenia
Drug(s) suspected as cause:
Estraderm
Dosage: unk biw
Administration route: Topical
Indication: Menopausal Symptoms
Start date: 1997-09-20
End date: 1999-01-01
Prempro
Dosage: .625/2.5mg qd
Administration route: Oral
Indication: Menopausal Symptoms
Start date: 1999-01-01
End date: 2001-04-01
Other drugs received by patient: Femara; Adriamycin PFS; Vicodin; Prozac; Tamoxifen Citrate; Cytoxan; Vicodin; Maxzide; Lopressor; Celexa
Possible Estraderm side effects in female
Reported by a consumer/non-health professional from United States on 2011-10-24
Patient: female, weighing 68.0 kg (149.7 pounds)
Reactions: Abdominal Pain, Lymphadenopathy, Metastases To Liver, Headache, Malaise, Hot Flush, Uterine Leiomyoma, Pneumothorax, Hypoxia, Hepatic Cirrhosis, Muscle Spasms, Back Pain, Intervertebral Disc Protrusion, Pneumonia, Ovarian Cyst, Musculoskeletal Discomfort, Osteopenia, Breast Calcifications, Diverticulum Intestinal, Breast Cancer Stage II, Insomnia, Dermal Cyst, Breast Necrosis, Portal Hypertension, General Physical Condition Abnormal, Impaired Work Ability, Pain, Bone Pain, Pelvic Pain, Pleural Effusion, Depression, Cholecystitis, Splenomegaly, Adrenal Mass, Blood Pressure Increased, Polyp, Dyspnoea, Lung Neoplasm, Rash, Deformity, Ascites, Osteoarthritis, Anxiety, Device Failure, Atrophic Vulvovaginitis, Arthralgia, Leukocytosis
Drug(s) suspected as cause:
Estraderm
Dosage: .05 mg, qw2
Indication: Menopause
Start date: 1999-01-01
End date: 2000-01-01
Premarin
Indication: Hormone Replacement Therapy
Cycrin
Dosage: 2.5 mg, unk
Administration route: Oral
Indication: Menopause
Start date: 1999-01-01
End date: 2000-01-01
Estrostep
Dosage: unk
Indication: Menopause
End date: 2001-01-01
Prempro
Dosage: .625/2.5 mg
Administration route: Oral
Indication: Menopause
Start date: 2000-01-01
End date: 2002-01-01
Medroxyprogesterone Acetate
Indication: Menopause
Provera
Indication: Hormone Replacement Therapy
|